文献速递头颈外科

阿司匹林服用与头颈癌:INHANCE联盟内的汇总分析

Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium.
PubMed 文献 · Head Neck · 2024-01-16

在INHANCE联盟的4项病例对照研究(2024例病例、4196例对照)中,阿司匹林服用与头颈癌总体风险呈负相关(OR=0.48;95%CI:0.26,0.91),喉癌结果相似(OR=0.54;95%CI:0.30,0.96)。服用时长的分析证实了头颈癌总体结果,并显示口咽癌和喉癌 also 呈负相关。

要点

  • 阿司匹林服用与头颈癌总体风险降低相关(OR=0.48;95%CI:0.26,0.91)。
  • 喉癌风险 similarly 降低(OR=0.54;95%CI:0.30,0.96)。
  • 服用时长分析显示口咽癌和喉癌 also 呈负相关。

核心结论

  • 本研究提示阿司匹林服用可能降低头颈癌风险,主要由喉癌和口咽癌风险降低驱动。

研究设计与样本

  • INHANCE联盟内4项病例对照研究,共2024例病例和4196例对照。
  • 采用逻辑回归估计各研究的OR和95%CI,并用DerSimonian-Laird随机效应模型汇总。
  • 服用时长与头颈癌关系的非线性用分数多项式建模。

主要发现

  • 阿司匹林与头颈癌总体呈负相关(OR=0.48;95%CI:0.26,0.91)。
  • 喉癌结果相似(OR=0.54;95%CI:0.30,0.96)。
  • 服用时长分析证实头颈癌总体结果,并显示口咽癌和喉癌 also 呈负相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin intake might be inversely associated with head and neck cancer (HNC). Thus, we investigated this relationship within the International Head and Neck Cancer Epidemiology (INHANCE) consortium. METHODS: Four case-control studies within the INHANCE consortium were included (2024 cases, 4196 controls). Study-specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression and subsequently pooled with DerSimonian-Laird random-effects model. Nonlinearity of the relationship between duration of intake and HNC was modeled with fractional polynomials. RESULTS: Aspirin was inversely associated with HNC overall (OR = 0.48; 95% CI: 0.26, 0.91). Results for laryngeal cancer were similar (OR = 0.54; 95% CI: 0.30, 0.96). Analysis on duration of intake confirmed findings for HNC overall, showing also inverse associations for oropharyngeal and laryngeal cancer. CONCLUSIONS: This study suggests that aspirin intake may reduce the risk of HNC, driven mainly by decreases in risk for laryngeal and oropharyngeal cancer.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Sassano M, Taborelli M, Boccia S, et al. Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium. Head Neck. 2024. PMID: 38229229. doi:10.1002/hed.27638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。